Clinical Trial

A Phase II Clinical Trial of HRS-1893 in the Treatment of Heart Failure With Preserved Ejection Fraction

Name: A Phase II Clinical Trial of HRS-1893 in the Treatment of Heart Failure With Preserved Ejection Fraction — clinical trial record (NCT07269717)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Recruiting Phase 2

View on ClinicalTrials.gov →

Summary

This study aims to evaluate the safety and tolerability of HRS-1893 in subjects with heart failure with preserved ejection fraction.

Protocol Amendment History 1 amendment

This ClinicalTrials.gov record has been amended once since 2025-11-26.

Status change: Not Yet Recruiting → Recruiting 2026-05-08

Trial Details

NCT Number	NCT07269717
Lead Sponsor	Shandong Suncadia Medicine Co., Ltd.
Conditions	Heart Failure With Preserved Ejection Fraction
Enrollment	48 participants
Start Date	2026-03-30
Primary Completion	2027-03 (estimated)
Study Completion	2027-05 (estimated)
Updated on ClinicalTrials.gov	2026-05-11